Understanding the pathogenesis of the development of the infectious process and the role of IFN-γ in the activation of the immune system in TB, made it possible to identify IFN-γ as a promising therapeutic option for improving treatment results and overcoming the development of bacterial resistance. The gene discussed is IFNG; the disease is tuberculosis.